Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
12 weeks 2 x 10 mL bottles 3 vials use 9 mL total
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand
According to those studies, users experienced: Significant reductions in cravings for sugar, fast food and salty foods Eating less at meals and feeling less hungry between meals Clinically supported increases in GLP-1 production and activity Additionally, product messaging highlights potential weight and body composition benefits such as losing up to 25 pounds, dropping body fat and maintaining or gaining muscle mass
Retrieved 13 September 2015
As such, the report says the drugs are already significantly influencing how millions of people in Britain eat, drink, exercise and shop, with around 70% of GLP-1 users spending less in appetite-led categories such as snacks, confectionery and crisps
